REFERENCES

• World Health Organization.The World Health Report 2001 ;Mental Health: New Understanding. New Understanding, New Hope. Geneva, Switzerland: World Health Organization; 2001.
   Google Scholar
• GoodwinFK.JamisonKR.Manic-Depressive Illness.2nd ed. New York, NY: Oxford University Press2007
   Google Scholar
• Martinez-AranA.VietaE.ColomF.et alCognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.Bipolar Disord.2004622423215117401
   PubMed Web of Science ®Google Scholar
• Martinez-AranA.VietaE.ReinaresM.et alCognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.Am J Psychiatry.200416126227014754775
   PubMed Web of Science ®Google Scholar
• VietaE.RosaAR.Evolving trends in the long-term treatment of bipolar disorder.World J Biol Psychiatry.2007841117366344
   PubMed Web of Science ®Google Scholar
• VietaE.GoikoleaJM.Atypical antipsychotics: newer options for mania and maintenance therapy.Bipolar Disord.20057(suppl 4)213315948764
   PubMed Web of Science ®Google Scholar
• BerkM.DoddS.Efficacy of atypical antipsychotics in bipolar disorder.Drugs.20056525726915631544
   PubMed Web of Science ®Google Scholar
• VietaE.PanicaliF.GoetzI.et alOlanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.J Affect Disord.2008106637217582508
   PubMed Web of Science ®Google Scholar
• FinkM.ECT in therapy-resistant mania: does it have a place?Bipolar Disord.2006830730916696837
   PubMed Web of Science ®Google Scholar
• ValentiM.BenabarreA.Garcia-AmadorM.et alElectroconvulsive therapy in the treatment of mixed states in bipolar disorder.Eur Psychiatry.200823535618191551
   PubMed Web of Science ®Google Scholar
• VietaE.Bipolar mixed states and their treatment.Expert Rev Neurother.20055636815853475
   PubMedGoogle Scholar
• VietaE.The treatment of mixed states and the risk of switching to depression.Eur Psychiatry.2005209610015797692
   PubMed Web of Science ®Google Scholar
• ColomF.VietaE.DabanC.et alClinical and therapeutic implications of predominant polarity in bipolar disorder.J Affect Disord.200693131716650901
   PubMed Web of Science ®Google Scholar
• VietaE.Managing Bipolar Disorder in Clinical Practice.London, UK: Current Medicine Group Ltd;2007
   Google Scholar
• FountoulakisKN.VietaE.Sanchez-MorenoJ.et alTreatment guidelines for bipolar disorder: a critical review.J Affect Disord.20058611015820265
   PubMed Web of Science ®Google Scholar
• BowdenCL.Key treatment studies of lithium in manic-depressive illness: efficacy and side effects.J Clin Psychiatry.199859(suppl 6)13199674932
   PubMed Web of Science ®Google Scholar
• SwannAC.BowdenCL.MorrisD.et alDepression during mania. Treatment response to lithium or divalproex.Arch Gen Psychiatry.19975437429006398
   PubMed Web of Science ®Google Scholar
• GoodwinGM.Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.Br J Psychiatry.19941641491528173817
   PubMed Web of Science ®Google Scholar
• BaldessariniRJ.TondoL.DavisP.et alDecreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.Bipolar Disord.2006862563917042835
   PubMed Web of Science ®Google Scholar
• Gonzalez-PintoA.MosqueraF.AlonsoM.et alSuicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.Bipolar Disord.2006861862417042834
   PubMed Web of Science ®Google Scholar
• BowdenCL.GrunzeH.MullenJ.et alA randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.J Clin Psychiatry.20056611112115669897
   PubMed Web of Science ®Google Scholar
• BowdenCL.BruggerAM.SwannAC.et alEfficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.JAMA.19942719189248120960
   PubMed Web of Science ®Google Scholar
• VietaE.Atypical antipsychotics in the treatment of mood disorders.CurrOpin Psychiatry.2003162327
   Google Scholar
• GarfinkelPE.StancerHC.PersadE.A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania.J Affect Disord.198022792886450787
   PubMed Web of Science ®Google Scholar
• JohnstoneEC.CrowTJ.FrithCD.etal.The Northwick Park “functional” psychosis study: diagnosis and treatment response.Lancet.198821191252899186
   PubMed Web of Science ®Google Scholar
• FreemanMP.StollAL.Mood stabilizer combinations: a review of safety and efficacy.Ami J Psychiatry.19981551221
   PubMed Web of Science ®Google Scholar
• PopeHG.JrMcElroy SL, Keck PE, Jr, et al. Valproate in the treatment of acute mania. A placebo-controlled study.Arch Gen Psychiatry.19914862681984763
   PubMed Web of Science ®Google Scholar
• TohenM.BakerRW.AltshulerLL.et alOlanzapine versus divalproex in the treatment of acute mania.Am J Psychiatry.20021591011101712042191
   PubMed Web of Science ®Google Scholar
• VietaE.Divalproex versus olanzapine in mania.J Clin Psychiatry.2003641266126714658978
   PubMed Web of Science ®Google Scholar
• ZajeckaJM.WeislerR.SachsG.et alA comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.J Clin Psychiatry.2002631148115512523875
   PubMed Web of Science ®Google Scholar
• BowdenCL.SwannAC.CalabreseJR.et alA randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.J Clin Psychiatry.2006671501151017107240
   PubMed Web of Science ®Google Scholar
• CurtisD.KerrM.NICE recommendations for valproate treatment are unhelpful.Br J Psychiatry.200518644715863754
   PubMed Web of Science ®Google Scholar
• OkumaT.Effects of carbamazepine and lithium on affective disorders.Neuropsychobiology.1993271381458232828
   PubMed Web of Science ®Google Scholar
• BallengerJC.PostRM.Therapeutic effects of carbamazepine in affective illness: a preliminary report.Commun Psychopharmacol.19782159175352607
   PubMedGoogle Scholar
• WeislerRH.KalaliAH.KetterTA.A multicenter, randomized, doubleblind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.J Clin Psychiatry.20046547848415119909
   PubMed Web of Science ®Google Scholar
• WeislerRH.KeckPE.JrSwannAC.et alExtended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.J Clin Psychiatry.20056632333015766298
   PubMed Web of Science ®Google Scholar
• LererB.MooreN.MeyendorffE.et alCarbamazepine versus lithium in mania: a double-blind study.J Clin Psychiatry.19874889933546274
   PubMed Web of Science ®Google Scholar
• SmallJG.KlapperMH.MilsteinV.et alCarbamazepine compared with lithium in the treatment of mania.Arch Gen Psychiatry.1991489159211929761
   PubMed Web of Science ®Google Scholar
• SmallJG.KlapperMH.MarhenkeJD.et alLithium combined with carbamazepine or haloperidol in the treatment of mania.Psychopharmacol Bull.1995312652727491378
   PubMed Web of Science ®Google Scholar
• MishoryA.YaroslavskyY.BersudskyY.et alPhenytoin as an antimanic anticonvulsant: a controlled study.Am J Psychiatry.200015746346510698828
   PubMed Web of Science ®Google Scholar
• PopovaE.LeightonC.BernabarreA.et alOxcarbazepine in the treatment of bipolar and schizoaffective disorders.Exp Rev Neurother.20077617626
   PubMedGoogle Scholar
• KleinDF.Importance of psychiatric diagnosis in prediction of clinical drug effects.Arch Gen Psychiatry.1967161181265333776
   PubMed Web of Science ®Google Scholar
• PrienRF.CaffeyEM.Jr Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group.Arch Gen Psychiatry.1972261461534551257
   PubMed Web of Science ®Google Scholar
• ShopsinB.GershonS.ThompsonH.et alPsychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.Arch Gen Psychiatry.19753234421089401
   PubMed Web of Science ®Google Scholar
• CooksonJ.SilverstoneT.WellsB.Double-blind comparative clinical trial of pimozideand chlorpromazine in mania. A test of the dopamine hypothesis.Acta PsychiatrScand.198164381397
   PubMed Web of Science ®Google Scholar
• SmulevichAB.KhannaS.EerdekensM.et alAcute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.Eur Neuropsychopharmacol.200515758415572276
   PubMed Web of Science ®Google Scholar
• MclntyreRS.BrecherM.PaulssonB.et alQuetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.Eur Neuropsychopharmacol.20051557358516139175
   PubMed Web of Science ®Google Scholar
• TohenM.GoldbergJF.Gonzalez-PintoArrillaga AM.et alA 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.Arch Gen Psychiatry.2003601218122614662554
   PubMed Web of Science ®Google Scholar
• SachsGS.GrossmanF.GhaemiSN.et alCombination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safetyAm J Psychiatry.20021591146115412091192
   PubMed Web of Science ®Google Scholar
• Muller-OerlinghausenB.RetzowA.HennFA.et alValproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.J Clin Psychopharmacol.20002019520310770458
   PubMed Web of Science ®Google Scholar
• VietaE.BourinM.SanchezR.et alEffectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.Br J Psychiatry.200518723524216135860
   PubMed Web of Science ®Google Scholar
• VietaE.RameyT.KellerD.et alZiprasidone in the treatment of acute mania: A 12-week placebo-controlled, haloperidol referenced study.J Psychopharmacol. In press.
   Google Scholar
• McElroySL.DessainEC.PopeHG.Jret alClozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.J Clin Psychiatry.1991524114141938976
   PubMed Web of Science ®Google Scholar
• BarbiniB.ScherilloP.BenedettiF.et alResponse to clozapine in acute mania is more rapid than that of chlorpromazine.Int Clin Psychopharmacol.1997121091129219046
   PubMed Web of Science ®Google Scholar
• CalabreseJR.KimmelSE.WoyshvilleMJ.et alClozapine for treatmentrefractory mania.Am J Psychiatry.19961537597648633686
   PubMed Web of Science ®Google Scholar
• HirschfeldRM.KeckPE.Jr Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.Am J Psychiatry.20041611057106515169694
   PubMed Web of Science ®Google Scholar
• KhannaS.VietaE.LyonsB.et alRisperidone in the treatment of acute mania: Double-blind, placebo-controlled study.Br J Psychiatry.200518722923416135859
   PubMed Web of Science ®Google Scholar
• YathamLN.GrossmanF.AugustynsI.et alMood stabilisers plus risperidone or placebo in the treatment of acute mania. International, doubleblind, randomised controlled trial.Br J Psychiatry.200318214114712562742
   PubMed Web of Science ®Google Scholar
• DwightMM.KeckPE.Jr Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorderLancet.19943445545557520110
   PubMed Web of Science ®Google Scholar
• VietaE.HerraizM.ParramonG.et alRisperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain.J Affect Disord.200272151912204313
   PubMed Web of Science ®Google Scholar
• VietaE.GoikoleaJM.CorbellaB.et alRisperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6month, multicenter, open study.J Clin Psychiatry.20016281882511816872
   PubMed Web of Science ®Google Scholar
• VietaE.HerraizM.FernandezA.et alEfficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).J Clin Psychiatry.20016262363011561935
   PubMed Web of Science ®Google Scholar
• VietaE.Olanzapine in bipolar disorder.Exp Opin Pharmacother.2004516131619
   PubMed Web of Science ®Google Scholar
• TohenM.SangerTM.McElroySL.et alOlanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.Am J Psychiatry.199915670270910327902
   PubMed Web of Science ®Google Scholar
• TohenM.JacobsTG.GrundySL.et alEfficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.Arch Gen Psychiatry.20005784184910986547
   PubMed Web of Science ®Google Scholar
• BerkM.IchimL.BrookS.Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.Int Clin Psychopharmacol.19991433934310565800
   PubMed Web of Science ®Google Scholar
• TohenM.ChengappaKN.SuppesT.et alEfficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.Arch Gen Psychiatry200259626911779284
   PubMed Web of Science ®Google Scholar
• TohenM.CalabreseJR.SachsGS.et alRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.Am J Psychiatry.200616324725616449478
   PubMed Web of Science ®Google Scholar
• VietaE.MullenJ.BrecherM.et alQuetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.Curr Med Res Opin.20052192393415969892
   PubMed Web of Science ®Google Scholar
• SachsG.ChengappaKN.SuppesT.et alQuetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.Bipolar Disord.2004621322315117400
   PubMed Web of Science ®Google Scholar
• YathamLN.VietaE.YoungAH.et alA double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.Int Clin Psychopharmacol.20072221222017519644
   PubMed Web of Science ®Google Scholar
• KeckPE.Jr Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.Am J Psychiatry.200316074174812668364
   PubMed Web of Science ®Google Scholar
• PotkinSG.KeckPE.Jr Segal S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.J Clin Psychopharmacol.20052530131016012271
   PubMed Web of Science ®Google Scholar
• FountoulakisKN.VietaE.SiamouliM.et alTreatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Ann Gen Psychiatry.200762717925035
   PubMedGoogle Scholar
• WeislerR.DunnJ.EnglishP.Ziprasidone in adjunctive treatment of acute bipolar mania: randomized, double-blind, placebo-controlled trial. Paper presented at:16th European College of Neuropsychopharmachology Congress. Prague, Czech Republic; 20-24 September. 2003
   Google Scholar
• Lyseng-WilliamsonKA.PerryCM.Aripiprazole: in acute mania associated with bipolar I disorder.CMS Drugs.200418367376
   Google Scholar
• KeckPE.Jr Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.Am J Psychiatry.20031601651165812944341
   PubMed Web of Science ®Google Scholar
• SachsG.SanchezR.MarcusR.et alAripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.J Psychopharmacol.20062053654616401666
   PubMed Web of Science ®Google Scholar
• VietaE.T'joenC.McQuadeRD.et alEfficacy of adjunctive aripiprazole to valproate or lithium in bipolar patients with mania who were partially non-reponsive to valproate/lithium: A placebo-controlled study.Am J Psychiatry. 2008. In press
   Google Scholar
• VietaE.RosS.GoikoleaJM.et alAn open-label study of amisulpride in the treatment of mania.J Clin Psychiatry.20056657557815889942
   PubMed Web of Science ®Google Scholar
• AmannB.SterrA.MerglR.et alZotepine loading in acute and severely manic patients: a pilot study.Bipolar Disord.2005747147616176441
   PubMed Web of Science ®Google Scholar
• MclntyreR.PanagidesJ.AlphsL.et alTreatment of mania in bipolar I disorder: a placebo- and olanzapine-controlled trial of asenapine (ARES 7501005). Paper presented at: 20th ECNP Congress. Vienna, Austria; October 13-17 2007
   Google Scholar
• MclntyreR.PanagidesJ.AlphsL.et alEfficacy and tolerability of asenapine and olanzapine in acute mania: A double-blind extension study (ARES 7501006). Paper presented at: 20th ECNP Congress. Vienna, Austria; October 13-17 2007
   Google Scholar
• ScottJ.ColomF.VietaE.A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders,int J Neuropsychopharmacol.20071012312916787554
   PubMed Web of Science ®Google Scholar
• ColomF.VietaE.Sudden glory revisited: cognitive contents of hypomania.Psychother Psychosom.20077627828817700048
   PubMed Web of Science ®Google Scholar
• BurgessS.GeddesJ.HawtonK.et alLithium for maintenance treatment of mood disorders.Cochrane Database Syst Rev.2001CD003013
   Google Scholar
• DavisJM.JanicakPG.HoganDM.Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.Acta Psychiatr Scand.199910040641710626918
   PubMed Web of Science ®Google Scholar
• GeddesJR.BurgessS.HawtonK.et alLong-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.Am J Psychiatry.200416121722214754766
   PubMed Web of Science ®Google Scholar
• CalabreseJR.BowdenCL.SachsG.et alA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.J Clin Psychiatry.2003641013102414628976
   PubMed Web of Science ®Google Scholar
• BowdenCL.CalabreseJR.SachsG.et alA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.Arch Gen Psychiatry.20036039240012695317
   PubMed Web of Science ®Google Scholar
• GoodwinFK.FiremanB.SimonGE.et alSuicide risk in bipolar disorder during treatment with lithium and divalproex.JAMA.20032901467147313129986
   PubMed Web of Science ®Google Scholar
• Abou-SalehMT.CoppenA.Who responds to prophylactic lithium?J Affect Disord.1986101151252941468
   PubMed Web of Science ®Google Scholar
• BowdenCL.CalabreseJR.McElroySL.et alA randomized, placebocontrolled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.Arch Gen Psychiatry.20005748148910807488
   PubMed Web of Science ®Google Scholar
• CalabreseJR.SheltonMD.RapportDJ.et alA 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.Am J Psychiatry.20051622152216116263857
   PubMed Web of Science ®Google Scholar
• LambertP.VenaudG.Comparative study of valpromide versus lithium in treatment of affective disorders.Nervure.199255765
   Google Scholar
• TohenM.KetterTA.ZarateCA.et alOlanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.Am J Psychiatry.20031601263127112832240
   PubMed Web of Science ®Google Scholar
• OkumaT.InanagaK.OtsukiS.et alA preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.Psychopharmacology.(Berl) 19817395966785799
   PubMed Web of Science ®Google Scholar
• DardennesR.EvenC.BangeF.et alComparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis.Br J Psychiatry.19951663783817788131
   PubMed Web of Science ®Google Scholar
• GreilW.Ludwig-MayerhoferW.ErazoN.et alLithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study.J Affect Disord.1997431 511619127824
   PubMed Web of Science ®Google Scholar
• GreilW.KleindienstN.ErazoN.et alDifferential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.J Clin Psychopharmacol.1998184554609864077
   PubMed Web of Science ®Google Scholar
• HartongEG.MolemanP.HoogduinCA.et alProphylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.J Clin Psychiatry.20036414415112633122
   PubMed Web of Science ®Google Scholar
• GoodwinGM.BowdenCL.CalabreseJR.et alA pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.J Clin Psychiatry.20046543244115096085
   PubMed Web of Science ®Google Scholar
• VietaE.Maintenance therapy for bipolar disorder: current and future management options.Exp Rev Neurother.20044S35S42
   PubMedGoogle Scholar
• MishoryA.WinokurM.BersudskyY.Prophylactic effect of phenytoin in bipolar disorder: a controlled study.Bipolar Disord.2003546446714636372
   PubMed Web of Science ®Google Scholar
• VietaE.ManuelGJ.Martinez-AranA.et alA double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.J Clin Psychiatry.20066747347716649836
   PubMed Web of Science ®Google Scholar
• SernyakMJ.WoodsSW.Chronic neuroleptic use in manic-depressive illness.Psychopharmacol Bull.1993293753817907185
   PubMedGoogle Scholar
• KukopulosA.ReginaldiD.LaddomadaP.et alCourse of the manicdepressive cycle and changes caused by treatment.Pharmakopsychiatr Neuropsychopharmakoi.198013 156167
   PubMedGoogle Scholar
• HummelB.DittmannS.ForsthoffA.et alClozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.Neuropsychobiology,200245(suppl 1)374211893876
   PubMed Web of Science ®Google Scholar
• SuppesT.WebbA.PaulB.et alClinical outcome in a randomized 1year trial of clozapine versus treatment as usual for patients with treatmentresistant illness and a history of mania.Am J Psychiatry.19991561164116910450255
   PubMed Web of Science ®Google Scholar
• BrownES.ThomasNR.CarmodyT.et alAtypical antipsychotics in bipolar and schizoaffective disorders.Pharmacopsychiatry.200134808111302568
   PubMed Web of Science ®Google Scholar
• YathamLN.BinderC.RiccardelliR.et alRisperidone in acute and continuation treatment of mania.Int Clin Psychopharmacol.20031822723512817157
   PubMed Web of Science ®Google Scholar
• YathamLN.BinderC.KusumakarV.et alRisperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.Int Clin Psychopharmacol.20041910310915076019
   PubMed Web of Science ®Google Scholar
• VietaE.NietoE.AutetA.et alA long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.World J Biol Psychiatry. 2008. In press.
   Google Scholar
• TohenM.GreilW.CalabreseJR.et alOlanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.Am J Psychiatry.20051621281129015994710
   PubMed Web of Science ®Google Scholar
• TohenM.ChengappaKN.SuppesT.et alRelapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.Br J Psychiatry.200418433734515056579
   PubMed Web of Science ®Google Scholar
• SajatovicM.BrescanDW.PerezDE.et alQuetiapine alone and added to a mood stabilizer for serious mood disorders.J Clin Psychiatry.20016272873211681770
   PubMed Web of Science ®Google Scholar
• VietaE.SuppesT.EggensI.et alEfficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).J Affect Disord. In press
   Google Scholar
• WeislerR.WarringtonL.DunnJ.et alAdjunctive ziprasidone in bipolar mania: short and long-term data. Program and abstracts of the American Psychiatric Association, Annual Meeting. New York, NY; May 1-6, 2004.
   Google Scholar
• KeckPE.JrCalabreseJR.McQuadeRD.et alA randomized, doubleblind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.J Clin Psychiatry.20066762663716669728
   PubMed Web of Science ®Google Scholar
• CartaMG.ZairoF.MellinoG.et alAn open label follow-up study on amisulpride in the add-on treatment of bipolar I patients.Clin Pract Epidemol Ment Health.2006219
   PubMedGoogle Scholar
• SienaertP.PeuskensJ.Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord. 20068304306
   Google Scholar
• TsaoCI.JainS.GibsonRH.et alMaintenance ECT for recurrent medication-refractory mania.J ECT.20042011811915167429
   PubMed Web of Science ®Google Scholar
• PerryA.TarrierN.MorrissR.et alRandomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment.BMJ.19993181491539888904
   PubMed Web of Science ®Google Scholar
• ColomF.VietaE.Martinez-AranA.et alA randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.Arch Gen Psychiatry.20036040240712695318
   PubMed Web of Science ®Google Scholar
• MiklowitzDJ.WisniewskiSR.MiyaharaS.et alPerceived criticism from family members as a predictor of the one-year course of bipolar disorder.Psychiatry Res.200614415316617011635
   PubMedGoogle Scholar
• ReinaresM.ColomF.Sanchez-MorenoJ.et alImpact of caregivers group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial.Bipolar Disord.20081051151918452447
   PubMed Web of Science ®Google Scholar
• ScottJPaykelE.MorrissR.et alCognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.Br J Psychiatry.200618831332016582056
   PubMed Web of Science ®Google Scholar
• LamDH.WatkinsER.HaywardP.et alA randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year.Arch Gen Psychiatry.20036014515212578431
   PubMed Web of Science ®Google Scholar
• LamD.WrightK.SmithN.Dysfunctional assumptions in bipolar disorder.J Affect Disord.20047919319915023494
   PubMed Web of Science ®Google Scholar
• FrankE.Interpersonal and social rhythm therapy: a means of improving depression and preventing relapse in bipolar disorder.J Clin Psychol.20076346347317417811
   PubMed Web of Science ®Google Scholar
• FrankE.SwartzHA.KupferDJ.Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder.Biol Psychiatry.20004859360411018230
   PubMed Web of Science ®Google Scholar
• ColomF.VietaE.Psychoeducation Manual for Bipolar Disorder. Cambridge, UK: Cambridge University Press; 2006.
   Google Scholar